It is still unclear why increased serum IGF-1 level may have a sheltery effect on the risk of cervical cancer, whereas the unfavourable effect of serum IGF-1 is addressed in certain sex hormone-related cancers, such as prostate cancer or breast cancer. The gene discussed is IGF1; the disease is breast cancer.